NewGenIvf Group Ltd

NIVF Nasdaq SEC CIK 1981662
Follow NewGenIvf Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · US GAAP
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income6 fiscal years
  • Revenue
  • Net income
−$5M$0$5M$10MFY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$4.7M$9.9M
FY24$5.4M−$524.6K
FY23$5.1M$130.2K
FY22$5.9M$458.7K
FY21$4.1M−$533
FY20--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−400%−200%0%200%400%FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2520.2%−226.9%209%
FY2433.6%−21.4%−9.7%
FY2332.7%0.8%2.5%
FY2225.9%6.7%7.7%
FY2124.9%4.8%0%
FY20---
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0$5MFY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$11.1M
FY24−$8.3M
FY23−$1.8M
FY22$1.6M
FY21$1.4M
FY20-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • NewGenIvf
  • Healthcare median
−100%0%100%200%300%FY20FY21FY22FY23FY24FY25
Show the numbers
YearNewGenIvfHealthcare median
FY25209%−30.6%
FY24−9.7%−47%
FY232.5%−58%
FY227.7%−80.4%
FY210%−71.9%
FY20-−62.2%